AUTHOR INFORMATION

Section 1 of 11

Authored by Robert E O'Connor, MD, MPH, Director of Education and Research, Department of Emergency Medicine, Christiana Care Health System; Professor of Emergency Medicine, Thomas Jefferson University

Robert E O'Connor, MD, MPH, is a member of the following medical societies: American Academy of Emergency Medicine, American Medical Association, and National Association of EMS Physicians

Edited by Edward Bessman, MD, Chairman, Department of Emergency Medicine, John Hopkins Bayview Medical Center; Assistant Professor, Department of Emergency Medicine, Johns Hopkins University; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Gary Setnik, MD, Chair, Department of Emergency Medicine, Mount Auburn Hospital; Assistant Professor, Division of Emergency Medicine, Harvard Medical School; John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School; and Jonathan Adler, MD, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital; Division of Emergency Medicine, Harvard Medical School

Author's Email:	Robert E O'Connor, MD, MPH
Editor's Email:	Edward Bessman, MD

eMedicine Journal, October 26 2005, VOLUME 6, Number 10

INTRODUCTION

Section 2 of 11

Background: Abdominal aortic aneurysm (AAA) is a relatively common, potentially life-threatening condition. It has a wide spectrum of presentations and should be considered in the differential diagnosis for a number of symptoms. AAA is usually the result of degeneration in the media of the arterial wall, resulting in a slow and continuous dilatation of the lumen of the vessel. In fewer than 5% of cases, AAA is caused by mycotic aneurysm of hematogenous origin. In these cases, local invasion of the intima and media gives rise to abscess formation and aneurysmal dilation of the vessel. Gram-positive organisms most commonly cause mycotic aneurysm. As with aneurysm of the thoracic aorta, AAA may be described as fusiform, which is circumferential, or saccular, which is more localized.

Pathophysiology: The 3 layers comprising the normal aorta are the intima, media, and adventitia. Structural and elastic properties of major arteries are mostly imparted by the media, which is composed of smooth muscle cells surrounded by elastin, collagen, and proteoglycans. AAA develops following degeneration of the media due to atherosclerotic changes. The degeneration ultimately may lead to widening of the vessel lumen and loss of structural integrity.

Most AAAs occur in association with advanced atherosclerosis. Atherosclerosis may induce AAA formation by causing mechanical weakening of the aortic wall with loss of elastic recoil, along with degenerative ischemic changes, through obstruction of the vasa vasorum. Many patients with advanced atherosclerosis do not develop AAA, while some patients having no evidence of atherosclerosis do. The observed association between atherosclerosis and AAA is probably not causative; however, atherosclerosis may represent a nonspecific secondary response to vessel wall injury that is induced by multiple factors.

Frequency:

• In the US: Ruptured AAA is the 13th-leading cause of death in the US, causing an estimated 15,000 deaths per year. The incidence of AAA is 2-4% in the adult population, and 11% of cases in that subset occur in males older than 65 years. Despite increased survival following diagnosis, incidence and crude mortality seem to be increasing.

Mortality/Morbidity: In 1988, 40,000 surgical reconstructions for AAA were performed in the US, with substantial mortality differences between elective versus emergency operations. As elective aneurysm repair has a mortality rate drastically lower than that associated with rupture, the emphasis must be on early detection and repair free from complications.

Race: White males have the highest incidence of AAA.

Sex: Males are affected 7 times more often than females.

Age: More than three fourths of patients with AAA are older than 60 years.

CLINICAL

Section 3 of 11

History: AAAs are usually asymptomatic until they expand or rupture. Patients may experience unimpressive back, flank, abdominal, or groin pain for some time prior to rupture. Isolated groin pain is a particularly insidious presentation. This occurs with retroperitoneal expansion and pressure on either the right or left femoral nerve. This symptom may be present without any other associated findings, and a high index of suspicion is necessary to make the diagnosis.

• Expanding AAA causes sudden, severe, and constant low back, flank, abdominal, or groin pain. Syncope may be the chief complaint, and pain may be a less significant symptom to the patient.

• Patients with a ruptured AAA may present in frank shock as evidenced by cyanosis, mottling, altered mental status, tachycardia, and hypotension.

• At least 65% of patients with ruptured AAA die from sudden cardiovascular collapse before arriving at a hospital.

• Patients at greatest risk for AAA are those who are older than 65 years and have peripheral atherosclerotic vascular disease.

• A history of smoking, chronic obstructive pulmonary disease (COPD), and hypertension often is elicited.

• Less frequent causes of AAA include Marfan and Ehlers-Danlos syndromes, collagen vascular diseases, and mycotic aneurysm.

• Patients who have a first-degree relative with AAA are at increased risk.

• It is important to note progressive symptoms (eg, abdominal or back pain, vomiting, syncope, claudication). These should alert the clinician to the possibility of expansion with imminent rupture.

Physical:

• While abrupt onset of pain due to AAA may be quite dramatic, associated physical findings may be very subtle.

• Patients may have normal vital signs in the presence of a ruptured AAA due to retroperitoneal containment of hematoma.

• Presence of a pulsatile abdominal mass is virtually diagnostic but is found in less than half of cases. It is more commonly seen with a ruptured aneurysm. In an obese abdomen, an AAA is more difficult to palpate. Even in 25% of patients known to have an aneurysm, vascular surgeons are unable to palpate a pulsatile mass while preparing the patient for surgery.

• Misdiagnosis is fairly common because the classic presentation of pain associated with hypotension, tachycardia, and a pulsatile abdominal mass is present in fewer than 30-50% of cases. The leading misdiagnosis is renal colic, as dissection of the renal artery may produce flank pain and hematuria.

• Presence of an abdominal bruit or lateral propagation of the aortic pulse wave offer subtle clues and may be more frequently found than the pulsatile mass.

• The clinician need not be afraid of properly palpating the abdomen because no evidence exists that aortic rupture can be precipitated by this maneuver.

Causes:

• Patients at greatest risk for AAA are those who are older than 65 years and have peripheral atherosclerotic vascular disease.

• A history of smoking, chronic obstructive pulmonary disease (COPD), and hypertension often is elicited.

• Less frequent causes of AAA include Marfan and Ehlers-Danlos syndromes, collagen vascular diseases, and mycotic aneurysm.

• Patients who have a first-degree relative with AAA are at increased risk.

DIFFERENTIALS

Section 4 of 11

Appendicitis, Acute
Cholelithiasis
Diverticular Disease
Gastritis and Peptic Ulcer Disease
Myocardial Infarction
Obstruction, Large Bowel
Obstruction, Small Bowel
Pancreatitis
Urinary Tract Infection, Female

Other Problems to be Considered:

Gastrointestinal bleed
Ischemic bowel
Nephrolithiasis
Musculoskeletal pain
Perforated gastrointestinal ulcer
Pyelonephritis
Pancreatitis

WORKUP

Section 5 of 11

Imaging Studies:

• More than 80% of patients with ruptured AAA present without previous diagnosis of AAA, which contributes to an initial misdiagnosis rate of 24-42%. A rational approach to diagnostic evaluation is predicated on a high degree of suspicion. Options for radiologic evaluation of AAA include plain radiography, ultrasonography, CT scan, MRI, and angiography.

• Plain radiography

• Plain radiographs often are obtained on patients with abdominal complaints before the diagnosis of AAA has been entertained. Using this method to evaluate patients with AAA is difficult because the only marginally specific finding, aortic wall calcification, is seen less than half of the time. Aortic wall calcification may appear without aneurysm rim calcification, which leads to a high false-negative rate.

• Do not order plain radiography for the sole purpose of evaluating suspected AAA because it wastes time, delays care, and places the patient at risk for aortic rupture and death because of its low diagnostic yield.

• Ultrasonography

• Ultrasonography is noninvasive and sensitive, may be performed at the bedside, and can detect free peritoneal blood.

• Limitations of the study include inability to detect leakage, rupture, branch artery involvement, and suprarenal involvement. Also, ability to image the aorta is reduced in the presence of bowel gas or obesity.

• The primary role of ultrasonography is to screen patients at risk for AAA, determine the size of the aneurysm, and observe the aneurysm over time.

• Significant portions of abdominal aorta (at least one third of its length) are not visualized on bedside emergency ultrasound in 8% of nonfasted patients. This rate is higher than reported for fasted patients receiving elective ultrasound for evaluation of their aortas.

• CT scan

• CT scan sensitivity for detecting AAA is nearly 100%, and the study offers certain advantages over ultrasound in defining aortic size, rostral-caudal extent, involvement of visceral arteries, and extension into the suprarenal aorta. In addition, CT scanning permits visualization of the retroperitoneum, is not limited by obesity or bowel gas, detects leakage, and permits concomitant evaluation of the kidneys.

• Spiral CT scan allows 3-dimensional imaging of abdominal contents, enhancing the ability to detect branch vessel and adjacent organ involvement.

• Major disadvantages of CT scanning include technician availability, cost, longer study time, exposure to contrast, and the need to send patients out of the department for an extended time.

• MRI

• MRI permits aorta imaging comparable to CT scanning and ultrasound without subjecting the patient to dye load or ionizing radiation. The technique may offer superior imaging of branch vessels compared to CT scan or ultrasound, but it is less valuable in assessing suprarenal extension and is not suitable in patients who are unstable. MRI may have a role in very stable patients with a severe dye allergy.

• Lack of widespread availability, need for a stable patient, incompatibility with monitoring equipment, and high cost limit its applicability.

• Angiography

• Angiography is useful in determining aortic anatomy and has been advocated for preoperative use if suspicion of suprarenal or thoracic aneurysm, femoral or popliteal aneurysm, renal artery stenosis, unexplained impairment of renal function, occlusive iliofemoral disease, or visceral ischemia exists.

• The test is limited by its invasiveness, cost, lack of operator availability, time involved, and risk of complications (eg, bleeding, perforation, embolization). Routine use of angiography in evaluation of AAA is not recommended.

• Digital subtraction angiography (DSA) requires less time, uses less contrast material, and is less invasive than conventional angiography. The technique is not widely available and offers no real advantage over conventional CT scanning.

TREATMENT

Section 6 of 11

Prehospital Care:

• Prehospital care of patients having symptoms compatible with or suggestive of aortic aneurysm or dissection consists of assuring adequate breathing, maintaining oxygenation, treating shock, and obtaining useful information concerning history in order to expedite treatment on ED arrival. All patients with suspected aortic aneurysm should receive 100% oxygen along with continuous ECG and vital sign monitoring while en route to hospital. Large-bore IVs (14- or 16-gauge) should be inserted en route if possible.

• Establishing diagnosis in the field is usually difficult or impossible, but certain salient features of aortic aneurysm or dissection may be observed. Both can pose a threat to life if not quickly recognized and treated. Patients older than 50 years with sudden onset of abdominal pain should be presumed to have a ruptured AAA and should receive attentive airway management and vigorous fluid resuscitation, as indicated.

• Patient presentation during the prehospital phase of care differs depending on whether the aneurysm is acutely expanding or leaking or whether it involves the thoracic or abdominal aorta. Radio communication with the receiving hospital permits the medical control physician to direct care, and it facilitates selection of a capable destination hospital while permitting the ED to mobilize appropriate resources.

• The physician directing prehospital care should request transport to a facility capable of operative treatment of an aortic aneurysm in the rare event that the diagnosis can be suspected based on prehospital information.

• Use of military antishock trousers (MAST) to reverse shock due to ruptured AAA may seem beneficial, but it may actually be detrimental. While their application theoretically offers temporary stabilization by compressing the leaking AAA and expanding hematoma, an undesirable reduction in cardiac output also occurs. Expedient transport of patients who are unstable is a therapeutic imperative for those who are deteriorating.

Emergency Department Care:

• Abdominal, back, or flank pain of sudden onset is characteristic of a rapidly expanding or ruptured AAA. The diagnosis should be entertained whenever a patient older than 50 years presents with abdominal pain, particularly when pain is associated with syncope or signs of hemorrhagic shock.

• Examine patients suspected of having AAA for the presence of a pulsatile mass, which, if present, mandates immediate surgical intervention.

• Manage hemorrhagic shock with fluid resuscitation, blood transfusion, and immediate surgical consultation.

• Treatment for coagulopathy may be initiated in the ED for patients on warfarin or heparin.

• Abdominal aortic aneurysm (AAA) rupture is believed to occur when the mechanical stress acting on the wall exceeds the strength of the wall tissue.

• Wall tension can be calculated using the Laplace Law for wall tension: P x R/W, where P = mean arterial pressure (MAP), R = radius of the vessel, and W = wall thickness of the vessel.

• AAA wall tension is a significant predictor of pending rupture. The actual tension in the AAA wall appears to be a more sensitive predictor of rupture than aneurysm diameter alone.

• For these reasons, the clinician may wish to achieve acute blood pressure control in patients with AAA and elevated blood pressure.

• Agents commonly used include antihypertensive agents and analgesics.

• Patients with leaking AAAs, if normotensive, do not require pharmacotherapy.

• In the setting of hypotension, reduction of blood pressure may be contraindicated.

• Initial therapeutic goals include elimination of pain and reduction of systolic blood pressure to 100-120 mm Hg, or to the lowest level commensurate with adequate vital organ (cardiac, cerebral, renal) perfusion.
  • Whenever systolic hypertension is present, beta-blockers can be used to reduce arterial dP/dt.

  • To prevent exacerbations in tachycardia and hypertension, treat patients with IV morphine sulfate. This reduces the force of cardiac contraction and the rate of rise of the aortic pressure (dP/dT). It then retards the propagation of the dissection and delays rupture.

Consultations:

• Screening men beginning at 65 years reduces the mortality from rupture and is cost-effective. Open thoracic and abdominal aneurysm repair has a mortality rate of around 8%, with myocardial infarction being a frequent cause of death. Preoperative reduction of cardiac risk by cardiac investigations and beta-blockade may reduce this mortality rate. Autologous transfusion techniques, such as acute normovolemic hemodilution and interoperative cell salvage, reduce the need for allogeneic blood and the complications associated with open surgery. Minimally invasive endovascular repair is now possible for 40% of AAA and an increasing proportion of thoracic aneurysms.

• The combination of screening, reduced preoperative risk, and new minimally invasive techniques extend aortic aneurysm treatment into an increasingly elderly population.

• Urgency of consultation is dictated by the stability of the patient. In patients who are stable but without symptoms, the diagnostic workup takes precedence. Consider consulting a radiologist to determine whether ultrasonography, CT scan, or MRI would be the most appropriate study.

• Follow-up with a vascular surgeon is warranted if the abdominal aorta exceeds 3 cm in diameter or if any segment is greater than 1.5 times the diameter of an adjacent section.

• Patients having AAA smaller than 4 cm in diameter require serial ultrasound twice per year. If the diameter increases by more than 0.5 cm over 6 months, or if it exceeds 4 cm, surgical repair usually is warranted.

• Immediately consult surgery for symptomatic patients with AAA. If hemodynamically stable, imaging modalities may be considered following discussion with surgical consultant.

• In cases that involve patients who are unstable, immediately consult a surgeon. Then, notify anesthesia and operating room personnel. A bedside ultrasound may be obtained while awaiting definitive treatment; however, it should not delay surgery. CT scanning is not appropriate in patients who are unstable.

MEDICATION

Section 7 of 11

The goals of pharmacotherapy are to reduce morbidity and to prevent complications.

Drug Category: Antihypertensives -- Used to reduce arterial dP/dt. For acute reduction of arterial pressure, the potent vasodilator sodium nitroprusside is very effective. To reduce dP/dt acutely, administer an IV beta-blocker in incremental doses until a heart rate of 60-80 beats/min is attained. When beta-blockers are contraindicated, such as in second- or third-degree atrioventricular block, consider using calcium channel blockers.

Drug Name	Esmolol (Brevibloc) -- Ultra–short-acting beta 2-blocker, particularly useful in patients with elevated arterial pressure, especially if surgery is planned. Can be discontinued abruptly if necessary. Normally used in conjunction with nitroprusside. May be useful as a means to test beta-blocker safety and tolerance in patients with history of obstructive pulmonary disease who are at uncertain risk for bronchospasm from beta-blockade. Elimination half-life is 9 min.
Adult Dose	Loading dose infusion: 250-500 mcg/kg/min for 1 min, followed by a 4-min maintenance infusion of 50 mcg/kg/min; repeat loading dose and follow with maintenance infusion using increments of 50 mcg/kg/min (for 4 min) if therapeutic effects not observed in 5 min; repeat sequence up to 4 times prn As desired BP is approached, omit loading infusion and reduce incremental dose in maintenance infusion from 50 mcg/kg/min to 25 mcg/kg/min or lower; may increase interval between titration steps from 5-10 min if desired
Pediatric Dose	Not established
Contraindications	Documented hypersensitivity; uncompensated congestive heart failure; bradycardia; cardiogenic shock; A-V conduction abnormalities
Interactions	Aluminum salts, barbiturates, NSAIDs, penicillins, calcium salts, cholestyramine, and rifampin may decrease bioavailability and plasma levels of esmolol, possibly resulting in decreased pharmacologic effect; cardiotoxicity of esmolol may increase when administered concurrently with sparfloxacin, astemizole (recalled from US market), calcium channel blockers, quinidine, flecainide, and contraceptives; toxicity of esmolol increases when administered concurrently with digoxin, flecainide, acetaminophen, clonidine, epinephrine, nifedipine, prazosin, haloperidol, phenothiazines, and catecholamine-depleting agents
Pregnancy	C - Safety for use during pregnancy has not been established.
Precautions	Beta-adrenergic blockers may mask signs and symptoms of acute hypoglycemia and clinical signs of hyperthyroidism; symptoms of hyperthyroidism, including thyroid storm, may worsen when medication is abruptly withdrawn; withdraw drug slowly and monitor patient closely

Drug Name	Labetalol (Normodyne, Trandate) -- Blocks alpha-1 beta 1-, and beta 2-adrenergic receptor sites, decreasing BP.
Adult Dose	20 mg (0.25 mg/kg for 80-kg patient) IV over 2 min initially, follow with 20-80 mg q10-15min until BP controlled Maintenance dose: 2 mg/min infusion; titrate to 5-20 mg/min; not to exceed a total dose of 300 mg
Pediatric Dose	Not established
Contraindications	Documented hypersensitivity; cardiogenic shock; pulmonary edema; bradycardia; atrioventricular block; uncompensated congestive heart failure; reactive airway disease; severe bradycardia
Interactions	Labetalol decreases effect of diuretics and increases toxicity of methotrexate, lithium, and salicylates; may diminish reflex tachycardia, resulting from nitroglycerin use, without interfering with hypotensive effects; cimetidine may increase labetalol blood levels; glutethimide may decrease labetalol effects by inducing microsomal enzymes
Pregnancy	C - Safety for use during pregnancy has not been established.
Precautions	Caution in impaired hepatic function; discontinue therapy if signs of liver dysfunction present; in elderly patients, a lower response rate and higher incidence of toxicity may be observed

Drug Name	Propranolol (Inderal, Betachron E-R) -- Class II antiarrhythmic nonselective beta-adrenergic receptor blocker. Has membrane-stabilizing activity and decreases automaticity of contractions. Propranolol is not suitable for emergency treatment of hypertension. Do not administer IV in hypertensive emergencies.
Adult Dose	40-80 mg PO bid initially; increase as required to usual range of 160-320 mg/d; up to 640 mg/d may be required
Pediatric Dose	0.5 mg/kg/d PO divided bid/qid and increase gradually q3-7d; usual dosage range is 2-4 mg/kg/d divided bid; not to exceed 2 mg/kg/d
Contraindications	Documented hypersensitivity; uncompensated congestive heart failure; bradycardia; cardiogenic shock; A-V conduction abnormalities
Interactions	Coadministration with aluminum salts, barbiturates, NSAIDs, penicillins, calcium salts, cholestyramine, and rifampin may decrease propranolol effects; calcium channel blockers, cimetidine, loop diuretics, and MAOIs may increase toxicity of propranolol; toxicity of hydralazine, haloperidol, benzodiazepines, and phenothiazines may increase with propranolol
Pregnancy	B - Usually safe but benefits must outweigh the risks.
Precautions	Beta-adrenergic blockade may decrease signs of acute hypoglycemia and hyperthyroidism; abrupt withdrawal may exacerbate symptoms of hyperthyroidism, including thyroid storm; withdraw drug slowly and monitor closely

Drug Name	Metoprolol (Lopressor) -- Selective beta 1-adrenergic receptor blocker that decreases automaticity of contractions. During IV administration, carefully monitor BP, heart rate, and ECG. When considering conversion from IV to PO dosage forms, use ratio of 2.5 mg PO to 1 mg IV metoprolol.
Adult Dose	100 mg/d qd or divided bid/tid initially; increase at 1-wk intervals prn up to a total of 450 mg/d prn
Pediatric Dose	Not established
Contraindications	Documented hypersensitivity; uncompensated congestive heart failure; bradycardia; cardiogenic shock; A-V conduction abnormalities; asthma
Interactions	Aluminum salts, barbiturates, NSAIDs, penicillins, calcium salts, cholestyramine, and rifampin may decrease bioavailability and plasma levels of metoprolol, possibly resulting in decreased pharmacologic effects; toxicity of metoprolol may increase with coadministration of sparfloxacin, phenothiazines, astemizole (recalled from US market), calcium channel blockers, quinidine, flecainide, and contraceptives; metoprolol may increase toxicity of digoxin, flecainide, clonidine, epinephrine, nifedipine, prazosin, verapamil, and lidocaine
Pregnancy	B - Usually safe but benefits must outweigh the risks.
Precautions	Beta-adrenergic blockade may reduce signs and symptoms of acute hypoglycemia and may decrease clinical signs of hyperthyroidism; abrupt withdrawal may exacerbate symptoms of hyperthyroidism, including thyroid storm; monitor patient closely and withdraw the drug slowly; during IV administration, carefully monitor blood pressure, heart rate, and ECG

Drug Name	Nitroprusside (Nitropress) -- Causes peripheral vasodilation by direct action on venous and arteriolar smooth muscle, thus reducing peripheral resistance. Commonly used IV because of its rapid onset and short duration of action. Easily titrated to desired effect. Nitroprusside is light sensitive and both bottle and tubing should be wrapped in aluminum foil. Prior to initiating nitroprusside, administer a beta-blocker to counteract physiologic response of reflex tachycardia that occurs when nitroprusside is used alone. This physiologic response will increase the shear forces against the aortic wall, thus increasing dP/dT. Objective is to keep heart rate between 60-80 bpm.
Adult Dose	0.5-3 mcg/kg/min IV; rates > 4 mcg/kg/min may lead to cyanide toxicity
Pediatric Dose	Administer as in adults
Contraindications	Documented hypersensitivity; subaortic stenosis, idiopathic hypertrophic and atrial fibrillation or flutter
Interactions	None reported
Pregnancy	C - Safety for use during pregnancy has not been established.
Precautions	Caution in increased intracranial pressure, hepatic failure, severe renal impairment, and hypothyroidism; in renal or hepatic insufficiency, nitroprusside levels may increase and can cause cyanide toxicity; sodium nitroprusside has the ability to lower blood pressure and thus should be used only in those patients with mean arterial pressures >70 mm Hg

Drug Category: Analgesics -- Pain control is essential to quality patient care. It ensures patient comfort, promotes pulmonary toilet and prevent exacerbations in tachycardia and hypertension.

Drug Name	Morphine sulfate (Astramorph, Infumorph) -- DOC for narcotic analgesia due to reliable and predictable effects, safety profile, and ease of reversibility with naloxone. Like fentanyl, morphine sulfate is easily titrated to desired level of pain control. Morphine sulfate administered IV may be dosed in a number of ways and is commonly titrated until desired effect obtained.
Adult Dose	Initial: 0.1 mg/kg IV/IM/SC Maintenance: 5-20 mg/70 kg q4h IV/IM/SC
Pediatric Dose	0.1-0.2 mg/kg/dose IV/IM/SC q2-4h prn
Contraindications	Documented hypersensitivity; hypotension; potentially compromised airway where establishing rapid airway control would be difficult
Interactions	Phenothiazines may antagonize analgesic effects of opiate agonists; tricyclic antidepressants, MAOIs, and other CNS depressants may potentiate adverse effects of morphine
Pregnancy	C - Safety for use during pregnancy has not been established.
Precautions	Caution in hypotension, respiratory depression, nausea, emesis, constipation, and urinary retention; caution in atrial flutter and other supraventricular tachycardias; has vagolytic action and may increase ventricular response rate

FOLLOW-UP

Section 8 of 11

Further Inpatient Care:

• Patients require admission when they are unstable or symptomatic, when they have significant comorbid conditions, or when the diagnosis is uncertain.

• Elderly patients or those with preexisting conditions (eg, emphysema, hypertension, congestive heart failure, coronary artery disease, cerebrovascular disease, renal insufficiency) may require stabilization prior to elective surgery.

• Asymptomatic patients with inflammatory AAA or AAA in association with distal emboli, pain, or bowel obstruction require emergent repair regardless of aneurysm size.

• Less invasive stenting procedures have recently been used in some centers to treat nonruptured AAAs.

Transfer:

• Surgical repair should be performed as expediently as possible by an experienced surgeon.

• Transfer of an unstable patient with AAA should only occur if the sending facility is incapable of operative care. Personnel skilled at resuscitation should accompany the transfer.

• Consideration can be given to transfer stable asymptomatic patients after appropriate imaging studies have excluded rupture, expansion, or leak.

Prognosis:

• The prognosis is guarded in patients who suffer rupture prehospital. More than 50% do not survive to the ED; of those who do, survival rate drops by about 1% per minute. However, survival rate is good in the subset of patients who are not in severe shock and who receive timely, expert surgical intervention.

Patient Education:

• For excellent patient education resources, visit eMedicine’s Circulatory Problems Center and Cholesterol Center. Also, see eMedicine’s patient education articles Aortic Aneurysm, High Cholesterol, and Cholesterol FAQs.

MISCELLANEOUS

Section 9 of 11

Medical/Legal Pitfalls:

• Patients who complain of back, flank, groin, or abdominal pain but have stable vital signs and do not appear ill present diagnostic challenges. They may be sent home or kept for extended periods in the ED while waiting for diagnostic testing for suspected ureterolithiasis or other benign abdominal conditions. If AAA ruptures and shock ensues, morbidity and mortality increase dramatically. Emergency physicians have been held liable for failure to diagnose AAA and obtain appropriate consultation in these situations. A high index of suspicion is necessary to avoid this medical-legal pitfall.

TEST QUESTIONS

Section 10 of 11

CME Question 1: Which of the following is not a risk factor for development of abdominal aortic aneurysm?

A: Age older than 65 years
B: Male sex
C: Black race
D: History of smoking or chronic obstructive pulmonary disease (COPD)
E: Ehlers-Danlos syndrome

The correct answer is C: Whites are more likely to develop abdominal aortic aneurysms than people of other races are. Other risk factors include peripheral atherosclerotic vascular disease, hypertension, Marfan syndrome, collagen vascular disease, mycotic aneurysms, and having a first-degree relative with an abdominal aortic aneurysm.

CME Question 2: Which statement regarding imaging of abdominal aortic aneurysms is false?

A: Plain radiographs are indicated.
B: Angiogram can be complicated by embolization.
C: Ultrasonography cannot detect branch artery involvement.
D: Sensitivity of CT scanning approximates 100% for detection of abdominal aortic aneurysms.
E: MRI is only suitable for stable, asymptomatic patients.

The correct answer is A: Plain radiographs are not indicated for patients with abdominal aortic aneurysms, because they are insensitive and nonspecific. Furthermore, plain radiographs often delay the diagnosis of a rupturing aneurysm; therefore, they are dangerous to obtain when the diagnosis is a possibility.

Pearl Question 1 (T/F): Previously diagnosed aneurysms are present in 50% of patients with ruptured abdominal aortic aneurysm.

The correct answer is False: Fewer than 20% of these patients carry a previous diagnosis, which contributes to an initial misdiagnosis rate of 24-42%. A rational approach to diagnostic evaluation is predicated on a high degree of suspicion.

Pearl Question 2 (T/F): The classic presentation of pain associated with tachycardia, hypotension, and a pulsatile abdominal mass is seen in 75% of patients with abdominal aortic aneurysm.

The correct answer is False: Fewer than 50% of these patients have these findings. Presence of an abdominal bruit or lateral propagation of the aortic pulse wave offer subtle clues and may be more frequently found than the pulsatile mass.

Pearl Question 3 (T/F): The most common misdiagnosis associated with a rupturing abdominal aortic aneurysm is diverticulitis.

The correct answer is False: Renal colic is the most common misdiagnosis in these patients, as dissection of the renal artery may produce flank pain and hematuria.

Pearl Question 4 (T/F): Abdominal palpation should be performed in patients with abdominal aortic aneurysm.

The correct answer is True: No evidence exists that palpation may lead to rupture or leaking.

BIBLIOGRAPHY

Section 11 of 11

• AbuRahma AF, Woodruff BA, Lucente FC, et al: Factors affecting survival of patients with ruptured abdominal aortic aneurysm in a West Virginia community. Surg Gynecol Obstet 1991 May; 172(5): 377-82[Medline].
• Adamson AS, Darke SG: Aneurysm repair in patients presenting with distal embolization. Am J Surg 1992 Feb; 163(2): 273[Medline].
• Banerjee A: Atypical manifestations of ruptured abdominal aortic aneurysms. Postgrad Med J 1993 Jan; 69(807): 6-11[Medline].
• Bengtsson H, Bergqvist D, Ekberg O, et al: Expansion pattern and risk of rupture of abdominal aortic aneurysms that were not operated on. Eur J Surg 1993 Sep; 159(9): 461-7[Medline].
• Blaivas M, Theodoro D: Frequency of incomplete abdominal aorta visualization by emergency department bedside ultrasound. Acad Emerg Med 2004 Jan; 11(1): 103-5[Medline].
• Blanchard JF, Armenian HK, Friesen PP: Risk factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol 2000 Mar 15; 151(6): 575-83[Medline].
• Bower TC, Cherry KJ Jr, Pairolero PC: Unusual manifestations of abdominal aortic aneurysms. Surg Clin North Am 1989 Aug; 69(4): 745-54[Medline].
• Daly KJ, Torella F, Ashleigh R, McCollum CN: Screening, diagnosis and advances in aortic aneurysm surgery. Gerontology 2004 Nov-Dec; 50(6): 349-59[Medline].
• Durham JR, Hackworth CA, Tober JC, et al: Magnetic resonance angiography in the preoperative evaluation of abdominal aortic aneurysms. Am J Surg 1993 Aug; 166(2): 173-7; discussion 177-8[Medline].
• Ernst CB: Abdominal aortic aneurysm. N Engl J Med 1993 Apr 22; 328(16): 1167-72[Medline].
• Frauenfelder T, Wildermuth S, Marincek B, Boehm T: Nontraumatic emergent abdominal vascular conditions: advantages of multi-detector row CT and three-dimensional imaging. Radiographics 2004 Mar-Apr; 24(2): 481-96[Medline].
• Kiell CS, Ernst CB: Advances in management of abdominal aortic aneurysm. Adv Surg 1993; 26: 73-98[Medline].
• LaRoy LL, Cormier PJ, Matalon TA, et al: Imaging of abdominal aortic aneurysms. AJR Am J Roentgenol 1989 Apr; 152(4): 785-92[Medline].
• Loughran CF: A review of the plain abdominal radiograph in acute rupture of abdominal aortic aneurysms. Clin Radiol 1986 Jul; 37(4): 383-7[Medline].
• Lyon M, Brannam L, Ciamillo L, Blaivas M: False positive abdominal aortic aneurysm on bedside emergency ultrasound. J Emerg Med 2004 Feb; 26(2): 193-6[Medline].
• Marston WA, Ahlquist R, Johnson G Jr, et al: Misdiagnosis of ruptured abdominal aortic aneurysms. J Vasc Surg 1992 Jul; 16(1): 17-22[Medline].
• National Center for Health Statistics: Vital statistics of the United States. 1991[Full Text].
• Pavone P, Di Cesare E, Di Renzi P, et al: Abdominal aortic aneurysm evaluation: comparison of US, CT, MRI, and angiography. Magn Reson Imaging 1990; 8(3): 199-204[Medline].
• Peppelenbosch N, Yilmaz N, van Marrewijk C, et al: Emergency treatment of acute symptomatic or ruptured abdominal aortic aneurysm. Outcome of a prospective intent-to-treat by EVAR protocol. Eur J Vasc Endovasc Surg 2003 Sep; 26(3): 303-10[Medline].
• Raghavan ML, Vorp DA, Federle MP, et al: Wall stress distribution on three-dimensionally reconstructed models of human abdominal aortic aneurysm. J Vasc Surg 2000 Apr; 31(4): 760-9[Medline].
• Reddy DJ, Shepard AD, Evans JR, et al: Management of infected aortoiliac aneurysms. Arch Surg 1991 Jul; 126(7): 873-8; discussion 878-9[Medline].
• Reichart M, Geelkerken RH, Huisman AB, et al: Ruptured abdominal aortic aneurysm: endovascular repair is feasible in 40% of patients. Eur J Vasc Endovasc Surg 2003 Nov; 26(5): 479-86[Medline].
• Salen P, Melanson S, Buro D: ED screening to identify abdominal aortic aneurysms in asymptomatic geriatric patients. Am J Emerg Med 2003 Mar; 21(2): 133-5[Medline].
• Stanford W, Rooholamini SA, Galvin JR: Ultrafast computed tomography in the diagnosis of aortic aneurysms and dissections. J Thorac Imaging 1990 Oct; 5(4): 32-9[Medline].
• Tefera G, Carr SC, Turnipseed WD: Endovascular aortic repair or minimal incision aortic surgery: Which procedure to choose for treatment of high-risk aneurysms? Surgery 2004 Oct; 136(4): 748-53[Medline].
• Vohra R, Reid D, Groome J, et al: Long-term survival in patients undergoing resection of abdominal aortic aneurysm. Ann Vasc Surg 1990 Sep; 4(5): 460-5[Medline].

eMedicine Journals > Emergency Medicine > Cardiovascular > Aneurysm, Abdominal

Please email us with any comments you have on our new chapter format.

Author Information | Introduction | Clinical | Differentials | Workup | Treatment | Medication | Follow-up | Miscellaneous | Test Questions | Bibliography